Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2019 | 04-2019 | 01-2019 | 10-2018 | 07-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,665 | -1,003 | -543 | -2,874 | -2,196 |
| Depreciation Amortization | 36 | 25 | 13 | 50 | 37 |
| Accounts receivable | 142 | -260 | -35 | 49 | -325 |
| Other Working Capital | 155 | -49 | -5 | -110 | -284 |
| Other Operating Activity | -41 | 333 | 77 | -158 | 579 |
| Operating Cash Flow | $-1,374 | $-955 | $-493 | $-3,043 | $-2,189 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -18 | -18 | -89 | -88 |
| Sale Of Investment | N/A | N/A | N/A | 3 | -449 |
| Purchase Sale Intangibles | -18 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -19 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-37 | $-18 | $-18 | $-86 | $-537 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 141 | 141 | 141 | 2,181 | 2,143 |
| Other Financing Activity | 283 | -14 | -30 | 258 | 254 |
| Financing Cash Flow | $424 | $126 | $111 | $2,439 | $2,397 |
| Beginning Cash Position | 1,309 | 1,305 | 1,306 | 2,042 | 2,015 |
| End Cash Position | 342 | 459 | 905 | 1,352 | 1,686 |
| Net Cash Flow | $-968 | $-847 | $-401 | $-690 | $-328 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,374 | -955 | -493 | -3,043 | -2,189 |
| Capital Expenditure | -18 | -18 | -18 | -89 | -88 |
| Free Cash Flow | -1,392 | -973 | -512 | -3,133 | -2,277 |